• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAS/RAF/MEK/ERK和PI3K/PTEN/AKT信号通路在恶性黑色素瘤进展及治疗中的作用

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy.

作者信息

Yajima Ichiro, Kumasaka Mayuko Y, Thang Nguyen Dinh, Goto Yuji, Takeda Kozue, Yamanoshita Osamu, Iida Machiko, Ohgami Nobutaka, Tamura Haruka, Kawamoto Yoshiyuki, Kato Masashi

机构信息

Unit of Environmental Health Sciences, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Kasugai, Aichi 487-8501, Japan.

出版信息

Dermatol Res Pract. 2012;2012:354191. doi: 10.1155/2012/354191. Epub 2011 Oct 12.

DOI:10.1155/2012/354191
PMID:22013435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3195305/
Abstract

Cutaneous malignant melanoma is one of the most serious skin cancers and is highly invasive and markedly resistant to conventional therapy. Melanomagenesis is initially triggered by environmental agents including ultraviolet (UV), which induces genetic/epigenetic alterations in the chromosomes of melanocytes. In human melanomas, the RAS/RAF/MEK/ERK (MAPK) and the PI3K/PTEN/AKT (AKT) signaling pathways are two major signaling pathways and are constitutively activated through genetic alterations. Mutations of RAF, RAS, and PTEN contribute to antiapoptosis, abnormal proliferation, angiogenesis, and invasion for melanoma development and progression. To find better approaches to therapies for patients, understanding these MAPK and AKT signaling mechanisms of melanoma development and progression is important. Here, we review MAPK and AKT signaling networks associated with melanoma development and progression.

摘要

皮肤恶性黑色素瘤是最严重的皮肤癌之一,具有高度侵袭性,且对传统治疗方法明显耐药。黑色素瘤的发生最初由包括紫外线(UV)在内的环境因素触发,紫外线会诱导黑素细胞染色体发生基因/表观遗传改变。在人类黑色素瘤中,RAS/RAF/MEK/ERK(MAPK)和PI3K/PTEN/AKT(AKT)信号通路是两条主要信号通路,并通过基因改变而持续激活。RAF、RAS和PTEN的突变有助于黑色素瘤的发展和进展过程中的抗凋亡、异常增殖、血管生成和侵袭。为了找到更好的患者治疗方法,了解黑色素瘤发展和进展的这些MAPK和AKT信号机制很重要。在此,我们综述与黑色素瘤发展和进展相关的MAPK和AKT信号网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bab/3195305/52fff63cbed1/DRP2012-354191.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bab/3195305/52fff63cbed1/DRP2012-354191.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bab/3195305/52fff63cbed1/DRP2012-354191.001.jpg

相似文献

1
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy.RAS/RAF/MEK/ERK和PI3K/PTEN/AKT信号通路在恶性黑色素瘤进展及治疗中的作用
Dermatol Res Pract. 2012;2012:354191. doi: 10.1155/2012/354191. Epub 2011 Oct 12.
2
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.RAF/MEK/ERK和PI3K/PTEN/AKT信号通路在恶性转化和耐药中的作用。
Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18.
3
Melanoma: molecular pathogenesis and emerging target therapies (Review).黑色素瘤:分子发病机制与新兴靶向治疗(综述)
Int J Oncol. 2009 Jun;34(6):1481-9. doi: 10.3892/ijo_00000277.
4
Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.人类子宫内膜癌和黑色素瘤中基因改变的探索:共享频繁异常PI3K/AKT级联反应的不同致瘤途径。
Oncol Rep. 2005 Dec;14(6):1481-5.
5
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy.靶向PI3K/AKT/mTOR和RAF/MEK/ERK信号通路进行癌症治疗。
Mol Biomed. 2022 Dec 21;3(1):47. doi: 10.1186/s43556-022-00110-2.
6
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.Ras/Raf/MEK/ERK和PI3K/PTEN/Akt/mTOR抑制剂:抑制这些通路对人类健康的原理及重要性
Oncotarget. 2011 Mar;2(3):135-64. doi: 10.18632/oncotarget.240.
7
The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma.RAS/RAF/MEK/ERK和PI3K/AKT信号通路为晚期黑色素瘤的有效治疗提供了分子靶点。
Front Biosci. 2005 Sep 1;10:2986-3001. doi: 10.2741/1755.
8
Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses.灰色马黑色素瘤和皮肤黑素细胞中ERK通路的组成性激活。
BMC Cancer. 2014 Nov 21;14:857. doi: 10.1186/1471-2407-14-857.
9
Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells.基础状态和治疗诱导的 AKT 激活介导了 ARRY-142886(AZD6244)在 BRAF 突变型人类皮肤黑素瘤细胞中对细胞死亡的抵抗。
Cancer Res. 2010 Nov 1;70(21):8736-47. doi: 10.1158/0008-5472.CAN-10-0902. Epub 2010 Oct 19.
10
Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.PTEN 缺失与 RAS 激活在黑色素瘤转移中的协同相互作用。
Small GTPases. 2010 Nov;1(3):161-164. doi: 10.4161/sgtp.1.3.14344.

引用本文的文献

1
Tumor antigen PRAME promotes melanoma growth by inactivating p53 through the SIRT1-DBC1 axis.肿瘤抗原PRAME通过SIRT1-DBC1轴使p53失活来促进黑色素瘤生长。
Oncogene. 2025 Sep 8. doi: 10.1038/s41388-025-03565-z.
2
Hydroxytyrosol Reprograms the Tumor Microenvironment in 3D Melanoma Models by Suppressing ERBB Family and Kinase Pathways.羟基酪醇通过抑制ERBB家族和激酶信号通路对三维黑色素瘤模型中的肿瘤微环境进行重编程。
Int J Mol Sci. 2025 Jul 20;26(14):6957. doi: 10.3390/ijms26146957.
3
Recent Developments in Targeting the Cell Cycle in Melanoma.

本文引用的文献

1
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.BRAF V600E 突变型黑色素瘤患者采用威罗菲尼治疗后生存改善。
N Engl J Med. 2011 Jun 30;364(26):2507-16. doi: 10.1056/NEJMoa1103782. Epub 2011 Jun 5.
2
Mutant BRAF melanomas--dependence and resistance.突变型 BRAF 黑色素瘤——依赖性和耐药性。
Cancer Cell. 2011 Jan 18;19(1):11-5. doi: 10.1016/j.ccr.2011.01.008.
3
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.黑色素瘤中 RAF 激酶开关介导的 BRAF 抑制剂获得性耐药可以通过共靶向 MEK 和 IGF-1R/PI3K 来克服。
黑色素瘤细胞周期靶向治疗的最新进展
Cancers (Basel). 2025 Apr 11;17(8):1291. doi: 10.3390/cancers17081291.
4
Biological Effect of Food for Special Medical Purposes (Nutramil Complex) on Melanoma Cells in In Vitro Study.特殊医学用途食品(Nutramil Complex)对黑色素瘤细胞的体外生物学效应研究
Nutrients. 2024 Dec 12;16(24):4287. doi: 10.3390/nu16244287.
5
UV radiation-induced peptides in frog skin confer protection against cutaneous photodamage through suppressing MAPK signaling.青蛙皮肤中紫外线辐射诱导产生的肽通过抑制丝裂原活化蛋白激酶信号传导来保护皮肤免受光损伤。
MedComm (2020). 2024 Jun 25;5(7):e625. doi: 10.1002/mco2.625. eCollection 2024 Jul.
6
Comparative Analysis of Olive-Derived Phenolic Compounds' Pro-Melanogenesis Effects on B16F10 Cells and Epidermal Human Melanocytes.橄榄油衍生酚类化合物对B16F10细胞和人表皮黑素细胞促黑素生成作用的比较分析
Int J Mol Sci. 2024 Apr 19;25(8):4479. doi: 10.3390/ijms25084479.
7
Endothelial Mitochondria Transfer to Melanoma Induces M2-Type Macrophage Polarization and Promotes Tumor Growth by the Nrf2/HO-1-Mediated Pathway.内皮细胞线粒体转移至黑色素瘤诱导 M2 型巨噬细胞极化,并通过 Nrf2/HO-1 介导的通路促进肿瘤生长。
Int J Mol Sci. 2024 Feb 3;25(3):1857. doi: 10.3390/ijms25031857.
8
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.CD133 依赖性激活磷酸肌醇 3-激酶/AKT/雷帕霉素靶蛋白信号通路在黑色素瘤进展和耐药中的作用。
Cells. 2024 Jan 26;13(3):240. doi: 10.3390/cells13030240.
9
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.黑色素瘤进展及治疗耐药的机制:癌症干细胞样细胞的作用
Cancers (Basel). 2024 Jan 22;16(2):470. doi: 10.3390/cancers16020470.
10
Olive leaf extract inhibits metastatic melanoma spread through suppression of epithelial to mesenchymal transition.橄榄叶提取物通过抑制上皮间质转化抑制转移性黑色素瘤的扩散。
Phytother Res. 2022 Oct;36(10):4002-4013. doi: 10.1002/ptr.7587. Epub 2022 Aug 10.
Cancer Cell. 2010 Dec 14;18(6):683-95. doi: 10.1016/j.ccr.2010.11.023.
4
Targeting BRAF for patients with melanoma.针对黑色素瘤患者的 BRAF 靶向治疗。
Br J Cancer. 2011 Feb 1;104(3):392-8. doi: 10.1038/sj.bjc.6606030. Epub 2010 Dec 7.
5
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.黑色素瘤通过 RTK 或 N-RAS 上调获得对 B-RAF(V600E)抑制的耐药性。
Nature. 2010 Dec 16;468(7326):973-7. doi: 10.1038/nature09626. Epub 2010 Nov 24.
6
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.COT 通过激活 MAP 激酶通路驱动 RAF 抑制耐药。
Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627. Epub 2010 Nov 24.
7
Effects of light smoking on extra-high-frequency auditory thresholds in young adults.轻度吸烟对年轻成年人超高频听觉阈值的影响。
Toxicol Ind Health. 2011 Mar;27(2):143-7. doi: 10.1177/0748233710382539. Epub 2010 Sep 21.
8
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.RAF 抑制剂的临床疗效需要在 BRAF 突变型黑色素瘤中广泛的靶标阻断。
Nature. 2010 Sep 30;467(7315):596-9. doi: 10.1038/nature09454.
9
Inhibition of mutated, activated BRAF in metastatic melanoma.转移性黑色素瘤中突变激活 BRAF 的抑制。
N Engl J Med. 2010 Aug 26;363(9):809-19. doi: 10.1056/NEJMoa1002011.
10
c-Ret-mediated hearing loss in mice with Hirschsprung disease.c-Ret 介导的先天性巨结肠症小鼠听力损失。
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13051-6. doi: 10.1073/pnas.1004520107. Epub 2010 Jun 29.